Concepedia

Xiaorui Fu

XF

Statistics

Publications

62

Citations

1.9K

H-Index

23

Active since

2013

Affiliations

First Affiliated Hospital of Zhengzhou University(Current)

Zhengzhou University

Nanchang University

The University of Texas MD Anderson Cancer Center

Henan Energy & Chemical Industry Group (China)

Xiaorui Fu is an author at First Affiliated Hospital of Zhengzhou University specializing in oncology, medicine, and lymphoid neoplasms.

Publications per year

2013–2024

62

Publications

62

Activity of pembrolizumab in relapsed/refractory NK/T-cell lymphoma

Xin Li, Mingzhi Zhang, Jiaqin Yan et al. · Journal of Hematology & Oncology · 2018 · 197 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

DDGP versus SMILE in Newly Diagnosed Advanced Natural Killer/T-Cell Lymphoma: A Randomized Controlled, Multicenter, Open-label Study in China

Xin Li, Yingying Cui, Zhenchang Sun et al. · Clinical Cancer Research · 2016 · 140 citations

Medicine, Oncology, Pharmacology +14

Analyzing and validating the prognostic value and mechanism of colon cancer immune microenvironment

Xinyi Wang, Jinzhong Duanmu, Xiaorui Fu et al. · Journal of Translational Medicine · 2020 · 100 citations · Full text

Medicine, Immunology, Oncology +17

c‐Myc mediated upregulation of long noncoding RNA SNHG12 regulates proliferation and drug sensitivity in natural killer/T‐cell lymphoma

Linan Zhu, Xudong Zhang, Xiaorui Fu et al. · Journal of Cellular Biochemistry · 2019 · 67 citations

Medicine, Molecular Genetics, Oncology +15

Efficacy and Safety of a Pegasparaginase-Based Chemotherapy Regimen vs an L-asparaginase–Based Chemotherapy Regimen for Newly Diagnosed Advanced Extranodal Natural Killer/T-Cell Lymphoma

Xinhua Wang, Lei Zhang, Xiangli Liu et al. · JAMA Oncology · 2022 · 58 citations · Full text

Medicine, Oncology, Pharmacology +13

1–5 of 62